The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index, and 2 are not checked yet.
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
Open accessAbstract
PPAR gamma is required for fat cell development and is the molecular target of antidiabetic thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal muscle, and liver. Unexpectedly, we found that inactivation of PPAR gamma in macrophages results in the development of significant glucose intolerance plus skeletal muscle and hepatic insulin resistance in lean mice fed a normal diet. This phenotype was associated with increased expression of inflammatory markers and impaired insulin signaling in adipose tissue, muscle, and liver. PPAR gamma-deficient macrophages secreted elevated levels of factors that impair insulin responsiveness in muscle cells in a manner that was enhanced by exposure to FFAs. Consistent with this, the relative degree of insulin resistance became more severe in mice lacking macrophage PPAR gamma following high-fat feeding, and these mice were only partially responsive to TZD treatment. These findings reveal an essential role of PPAR gamma in macrophages for the maintenance of whole-body insulin action and in mediating the antidiabetic actions of TZDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in PPARγ deficient mice exhibit impaired M2 macrophage function and susceptibility to diet-induced inflammation and insulin resistance [29,65–67].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [66]
In the citing paper
“thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
In the citing paper
“Treatment of macrophages with the insulin-sensitizing drugs thiazolidinediones (TZDs), which are PPARγ ligands, polarizes macrophages toward the M2/antiinflammatory state, thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citationA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,061
Gralton, B. (2008) · Art monthly Australia · Cited by 3,001
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Self-citationDeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,287
Self-citationSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Preiss, J., Loomis, C. R., Bishop, W. R., Stein, R. B., Niedel, J. E., & Bell, R. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84420-4 · Cited by 981
He, W., Barak, Y., Hevener, A. L., Olson, P., Liao, D., Le, J., Nelson, M. C., Ong, E. S., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 978
Self-citationResistin is expressed in human macrophages and directly regulated by PPARγ activators
Patel, L., Buckels, A. C., Kinghorn, I. J., Murdock, P. R., Holbrook, J. D., Plumpton, C., Macphee, C. H., & Smith, S. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02841-3 · Cited by 920
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B. H., Beerdsen, P., Joyce, M., & Olefsky, J. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 914
Self-citationRole of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
Li, A. C., Brown, K. K., Silvestre, M., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 836
Self-citationSuganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251608.09329.9a · Cited by 820
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 770
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Self-citationShyng, S., Lehmann, S., Moulder, K. L., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30221 · Cited by 704
Liu, X. S., Brutlag, D. L., & Liu, J. S. (2002) · Nature Biotechnology · doi:10.1038/nbt717 · Cited by 670
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Self-citationPeroxisome Proliferator–Activated Receptor γ and Metabolic Disease
Willson, T. M., Lambert, M. H., & Kliewer, S. A. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.341 · Cited by 590
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 580
Self-citationMuscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G. K., Olson, P., Wilkes, J. J., Evans, R. M., & Olefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 501
Self-citationChavez, J. A., & Summers, S. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.020 · Cited by 498
Metabolic syndrome: Definition, pathophysiology, and mechanisms
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.013 · Cited by 486
Sharma, A. M., & Staels, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1268 · Cited by 483
c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 441
Welch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., & Glass, C. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031789100 · Cited by 436
Self-citationMetabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B. M., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 419
Self-citationNorris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
Self-citationPPARγ AND G LUCOSE H OMEOSTASIS
Picard, F., & Auwerx, J. H. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 412
Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377
Self-citationAkiyama, T. E., Sakai, S., Lambert, G. C., Nicol, C. J. B., Matsusue, K., Pimprale, S., Lee, Y., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
Self-citationIncreased CD36 protein as a response to defective insulin signaling in macrophages
Liang, C.-P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I. A., Accili, D., & Tall, A. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19528 · Cited by 233
Determination of coenzyme A and acetyl CoA in tissue extracts
Allred, J. B., & Guy, D. G. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90312-1 · Cited by 196
In Vivo Expression of the Novel CXC Chemokine BRAK in Normal and Cancerous Human Tissue
Frederick, M. J., Henderson, Y. C., Xu, X., Deavers, M. T., Sahin, A. A., Wu, H., Lewis, D. E., El‐Naggar, A. K., & Clayman, G. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65067-5 · Cited by 185
Frayn, K. N., & Maycock, P. F. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39849-7 · Cited by 173
Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients
Sh, T., Sanctis, J. B. D., Briceño, L., Hernandez, N., & Finol, H. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810419 · Cited by 163
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ∞ AND METABOLIC DISEASE
Willson, T. M., Lambert, M. H., & Kliewer, S. A. (2001) · Cited by 154
Rajala, M. W., Lin, Y., Ranalletta, M., Yang, X. M., Qian, H., Gingerich, R., Barzilai, N., & Scherer, P. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0048 · Cited by 153
Ibrahimi, A., Teboul, L., Gaillard, D., Amri, E., Ailhaud, G. P., Young, P. W., Cawthorne, M. A., & Grimaldi, P. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09853-0 · Cited by 137
Liu, Y., Herschkovitz, A., Boura‐Halfon, S., Ronen, D., Paz, K., LeRoith, D., & Zick, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9668-9681.2004 · Cited by 127
Auwerx, J. H. (2002) · Cited by 127
PPAR influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
Nicol, C. J. B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh160 · Cited by 120
From promoter sequence to expression
Segal, E., Barash, Y., Simon, I., Friedman, N., & Koller, D. (2002) · doi:10.1145/565196.565231 · Cited by 109
Schiller, N. K., Kubo, N., Boisvert, W. A., & Curtiss, L. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096724 · Cited by 104
Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and mice
Fujiwara, T., Okuno, A., Yoshioka, S., & Horikoshi, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90056-x · Cited by 100
Casteleijn, E., Kuiper, J., van Rooij, H. C., Kamps, J. A. A. M., Koster, J. F., & van Berkel, T. J. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69124-0 · Cited by 97
A Simple Hyper-Geometric Approach for Discovering Putative Transcription Factor Binding Sites
Barash, Y., Bejerano, G., & Friedman, N. (2001) · Lecture notes in computer science · doi:10.1007/3-540-44696-6_22 · Cited by 94
PromoSer: a large-scale mammalian promoter and transcription start site identification service
Halees, A. S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg549 · Cited by 84
PPAR‐γ expression modulates insulin sensitivity in C2C12 skeletal muscle cells
Verma, N. K., Singh, J., & Dey, C. S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706002 · Cited by 65
Norris, A. W., Chen, L., Fisher, S. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317305 · Cited by 53
Li, A. C., Binder, C. J., Gutierrez, A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418730 · Cited by 39
Proceedings of the sixth annual international conference on Computational biology
Myers, E. W., Hannenhalli, S. S., Sankoff, D., Istrail, S., Pevzner, P. A., Waterman, M., USA, R. 6. A. I. C. O. C. M. B. 2. W. D., Association for Computing Machinery-Digital Library, ACM Special Interest Group on Algorithms & Computation Theory, & SIGs, A. (2002) · Cited by 24
Research works printed but not linked: 3
- Ibrahimi, 1994, Mol. Pharmacol., 46, 1070
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1172/JCI200419528 · DOI
Cited by
Sorted by citations
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Self-citationInflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Metadata
- Authors
- Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., Folian, B., Subramaniam, S., Gonzalez, F. J., Glass, C. K., & Ricote, M.
- Affiliations
- University of California San Diego (US)
- University of California System (US)
- The University of Melbourne (AU)
- Baker Heart and Diabetes Institute (AU)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1658-1669
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1868788
- OpenAlex
- W2131598118
- Cited by
- 459
- References
- 71
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 23 · 2017: 22 · 2016: 18 · 2015: 28 · 2014: 32 · 2013: 49 · 2012: 41
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Pfizer
- Takeda Pharmaceutical Company
- Ministerio de Economía y Competitividad
- National Institutes of Health (DK 074868, DK-063491, GM-069338)
- University of California, San Diego (DK063491)
- National Heart, Lung, and Blood Institute (P50HL056989, HL-56989)
- National Institute of General Medical Sciences (U54GM069338, GM 069338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, DK 074868, DK 60484, DK-33651, K01DK060484, R37DK033651, R21DK073227, P01DK074868, DK73227, R01DK033651, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PPARγ, macrophages, thiazolidinediones, insulin resistance, insulin sensitivity, skeletal muscle, liver, adipose tissue, impaired glucose tolerance, inflammation, insulin signaling, fatty acids, high-fat diet, antidiabetic drugs
- MeSH terms
- Animals, Base Sequence, Hypoglycemic Agents, Insulin Resistance, Liver, Macrophages, Mice, Transgenic, Promoter Regions, Genetic, Adipocytes, DNA Primers, Mice, Knockout, Muscle, Skeletal, Gene Expression Profiling, Thiazolidinediones, PPAR gamma, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
